AlphaFold predicted structure
ITM2B · Q9Y287

Mean pLDDT
75.4/ 100
Confident
266 residues
Confidence breakdown
- Very high(≥ 90)42%
- Confident(70–90)24%
- Low(50–70)13%
- Very low(< 50)20%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
integral membrane protein 2B
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Adult onset leukodystrophy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedAdult onset neurodegenerative disorder
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedEarly onset dementia (encompassing fronto-temporal dementia and prion disease)
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial cerebral small vessel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRetinal disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownABri amyloidosis
ADan amyloidosis
ITM2B amyloidosis
retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
AL amyloidosis
retinoblastoma
enteritis
digestive system disorder
self-injurious ideation
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Integral membrane protein 2B
Plays a regulatory role in the processing of the amyloid-beta A4 precursor protein (APP) and acts as an inhibitor of the amyloid-beta peptide aggregation and fibrils deposition. Plays a role in the induction of neurite outgrowth. Functions as a protease inhibitor by blocking access of secretases to APP cleavage sites
ITM2B · Q9Y287

Mean pLDDT
75.4/ 100
Confident
266 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0